Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CDIB BioScience Venture Management (CBVM) is a specialized venture capital firm focused on the life sciences and healthcare sectors, operating as a subsidiary of CDIB Capital Group (part of China Development Financial). Founded in 2001 and headquartered in San Diego with operations in Taipei, the firm identifies and supports high-potential biotechnology, pharmaceutical, and medical device companies across the United States and Asia. CBVM is notable for its "incubation" model, where it provides both capital and strategic management to foster the growth of early-stage companies, such as HenKan Pharmaceutical. Its investment portfolio has included successful exits and prominent names like Cadence Pharmaceuticals, Senhwa Biosciences, and Ocera Therapeutics, bridging the gap between the US and Taiwan biotech ecosystems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CDIB BioScience.